Genprex Making Progress on Branding for its Lead Cancer Therapy, Oncoprex

Genprex Inc (NASDAQ:GNPX) Chairman and CEO Rodney Varner tells Proactive Investors the biotech has initiated the first phase of branding for its lead drug candidate and has completed the creation and submission of non-proprietary drug name selections to the USAN Council.

 
STAY IN THE KNOW WITH
EMAIL NEWS ALERTS
 
Don't miss out. Get our news delivered to your inbox.
 

 
close-link
 
Get Email News Alerts
 
close-link